Surgical Innovations Group PLC
Company Profile
- Business description- Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery (SI Brand), along with its label products through original equipment manufacturer (OEM) relationships, including precision engineering markets (PE). The group's operating segments are SI Brand, OEM, and Distribution. The majority of its revenue is generated from the SI Brand segment, which is involved in the research, development, manufacture, and distribution of SI-branded minimally invasive devices. Geographically, the group derives a majority of its revenue from the United Kingdom, followed by Europe, the United States, the Asia-Pacific region, and the Rest of the world. 
- Contact- Clayton Wood House 
 6 Clayton Wood Bank
 LeedsLS16 6QZ
 GBR- T: +44 1132307597 
- Sector- Healthcare - Stock type- Defensive 
- Industry- Medical Devices - Fiscal Year End- 31 December 2025 - Employees- 88 
Stocks News & Analysis
stocks
Microsoft earnings: Strong, including Azure, but overall guidance is in line
stocks
After earnings, is Tesla stock a buy, a sell, or fairly valued?
Morningstar Investment Ideas
Markets
| Index | Last price | Change | % Change | 
|---|---|---|---|
| All Ordinaries | 9,178.00 | 28.70 | -0.31% | 
| CAC 40 | 8,113.47 | 43.82 | -0.54% | 
| DAX 40 | 23,944.08 | 174.81 | -0.72% | 
| Dow JONES (US) | 47,595.62 | 73.50 | 0.15% | 
| FTSE 100 | 9,717.80 | 42.26 | -0.43% | 
| HKSE | 25,906.65 | 376.04 | -1.43% | 
| NASDAQ | 23,793.46 | 212.31 | 0.90% | 
| Nikkei 225 | 52,411.34 | 1,085.73 | 2.12% | 
| NZX 50 Index | 13,548.32 | 89.03 | 0.66% | 
| S&P 500 | 6,854.53 | 32.19 | 0.47% | 
| S&P/ASX 200 | 8,881.90 | 31.30 | -0.35% | 
| SSE Composite Index | 3,954.79 | 32.11 | -0.81% |